Kodak Becomes a Pharma Company, AP Switches to Sony, RIP John Lewis

With a $765 million loan under the U.S. Defense Production Act, Kodak has pivoted from film chemistry to pharmaceutical ingredients. The loan sent Kodak's stock price soaring from $2.61 to as high as $60 before settling in the low $20s. Eyebrows were also raised when it was revealed that Kodak Executive Chairman Jim Continenza scored a stock option grant the day before the announcement that could net him close to $100 million. Also, Judge Nelson Lee stays his own ruling for three weeks t...